|
シモジマ ケイコ
Shimojima Keiko
下島 圭子 所属 医学部 医学科(東京女子医科大学病院) 職種 講師 |
|
| 論文種別 | 症例報告 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | A novel TUBB3 mutation in a sporadic patient with asymmetric cortical dysplasia. |
| 掲載誌名 | 正式名:American Journal of Medical Genetics. Part A 略 称:Am J Med Genet A ISSNコード:15524825/15524833 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 170A(4),pp.1076-1079 |
| 著者・共著者 | Shimojima K, Okamoto N, Yamamoto T |
| 発行年月 | 2016/04 |
| 概要 | Recent advances in molecular technology have led to the discovery of several genes related to human malformations of cortical development (MCDs). The beta-tubulin class III gene (TUBB3) was identified as a gene responsible for MCDs. Although mouse-model experiments have not revealed any findings of neuronal migration disorders, human TUBB3 mutations have been identified in patients with congenital fibrosis of the extraocular muscles. Since the discovery of a TUBB3 mutation, only 15 mutations have been identified. In this study, comprehensive mutation screening through next-generation sequencing identified a novel TUBB3 mutation (p.Ser230Leu) in a sporadic patient with moderate developmental delay associated with mild MCD. Compared to patients with the alpha-tubulin class 1a gene (TUBA1A) mutations, patients with TUBB3 mutations show milder phenotypic manifestations and milder MCD. Therefore, patients with milder MCD manifestations may be under-diagnosed, and TUBB3 mutations may be rarely identified. Additional genotype-phenotype information should be accumulated for further understanding of the TUBB3 functional relevance. |
| DOI | 10.1002/ajmg.a.37545 |
| PMID | 26739025 |